PPARA and metabolic dysfunction-associated steatotic liver disease: Although the underlying mechanisms have not yet been fully clarified, multi-omic analysis has suggested that OCPs favor NAFLD by altering the hepatic expression of genes involved in liver steatosis, PPAR signaling and fatty acid metabolism, inflammation, and necrosis [90].